Tag Archives: PALFORZIA

Aimmune Therapeutics’ PALFORZIA the first-ever treatment option approved for peanut allergy in the EU

(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release